Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study

M. Boyer; K. Horwood; N. Pavlakis; P. De Souza; Michael Millward; B. Stein; M. Johnston; F. Abell; D. Rischin

doi:10.1111/j.1743-7563.2012.01540.x

Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study

M. Boyer, K. Horwood, N. Pavlakis, P. De Souza, Michael Millward, B. Stein, M. Johnston, F. Abell, D. Rischin

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	248-254
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	8
DOIs	https://doi.org/10.1111/j.1743-7563.2012.01540.x
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1743-7563.2012.01540.x

Cite this

Boyer, M., Horwood, K., Pavlakis, N., De Souza, P., Millward, M., Stein, B., Johnston, M., Abell, F., & Rischin, D. (2012). Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study. Asia-Pacific Journal of Clinical Oncology, 8, 248-254. https://doi.org/10.1111/j.1743-7563.2012.01540.x

@article{b6df9d72220d4f0f92fc365737b797ab,

title = "Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study",

author = "M. Boyer and K. Horwood and N. Pavlakis and {De Souza}, P. and Michael Millward and B. Stein and M. Johnston and F. Abell and D. Rischin",

year = "2012",

doi = "10.1111/j.1743-7563.2012.01540.x",

language = "English",

volume = "8",

pages = "248--254",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "John Wiley & Sons",

}

Boyer, M, Horwood, K, Pavlakis, N, De Souza, P, Millward, M, Stein, B, Johnston, M, Abell, F & Rischin, D 2012, 'Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study', Asia-Pacific Journal of Clinical Oncology, vol. 8, pp. 248-254. https://doi.org/10.1111/j.1743-7563.2012.01540.x

TY - JOUR

T1 - Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study

AU - Boyer, M.

AU - Horwood, K.

AU - Pavlakis, N.

AU - De Souza, P.

AU - Millward, Michael

AU - Stein, B.

AU - Johnston, M.

AU - Abell, F.

AU - Rischin, D.

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1743-7563.2012.01540.x

DO - 10.1111/j.1743-7563.2012.01540.x

M3 - Article

C2 - 22898114

SN - 1743-7555

VL - 8

SP - 248

EP - 254

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

ER -